Search
Repotrectinib
go.drugbank.com/drugs/DB16826ApprovedInvestigationalThis approval is based on favorable results from the TRIDENT-1 study, where the objective response rate was 79% in TKI-naive patients and 38% in TKI-pretreated patients respectively.[L48741] … [A262056] ROS1 mutations are one of the defined oncogenic drives of NSCLC, and the solvent-front mutation ROS1 G2032R is responsible for 50 to 60% of [crizotinib]-resistant cases.
Categories: Antineoplastic and Immunomodulating AgentsE3 ubiquitin ligase TRAF3IP2
go.drugbank.com/bio_entities/BE0011632TargetHumansTransfers ubiquitin from E2 ubiquitin-conjugating enzyme UBE2V1-UBE2N to substrate protein (PubMed:19825828). … and MAPkinase pathways (PubMed:19825828)
Synonyms: Connection to IKK and SAPK/JNKE3 ubiquitin-protein ligase CHIP
go.drugbank.com/bio_entities/BE0021260TargetHumansUbiquitinates EPHA2 and may regulate the receptor stability and activity through proteasomal degradation (PubMed:19567782). … Acts as a co-chaperone for HSPA1A and HSPA1B chaperone proteins and promotes ubiquitin-mediated protein degradation (PubMed:27708256).
Synonyms: STIP1 homology and U box-containing protein 1Cefotiam
go.drugbank.com/drugs/DB00229ApprovedOne of the cephalosporins that has a broad spectrum of activity against both gram-positive and gram-negative microorganisms.
Aluminium phosphate
go.drugbank.com/drugs/DB14517ApprovedInvestigationalCategories: Alimentary Tract and Metabolism, Aluminum and magnesium containing antacidsOxymorphone
go.drugbank.com/drugs/DB01192ApprovedVet approvedAn opioid analgesic with actions and uses similar to those of morphine, apart from an absence of cough suppressant activity. … It may also be used as an adjunct to anesthesia (From Martindale, The Extra Pharmacopoeia, 30th ed, p1092).
Products: Numorphan Suppository 5mgAvutometinib
go.drugbank.com/drugs/DB15254ApprovedInvestigational[A273948] Avutometinib was approved by the US FDA in May 2025 in a co-package alongside [defactinib] (called Avmapki Fakzynja) for the treatment of recurrent KRAS-mutated low-grade serous ovarian cancer … [L53203,L53198] The MAPK pathway is implicated in variety of cancers, playing a key role in tumor cell proliferation, differentiation and survival.
Phosphocreatine
go.drugbank.com/drugs/DB13191InvestigationalNutraceuticalskeletal muscles of vertebrates where it serves a critical role as a rapidly acting energy buffer for muscle cell actions like contractions via its ability to regenerate adenosine triphosphate (ATP) from … Phosphocreatine - or creatine phosphate - is the phosphorylated form of creatine.
Categories: Amino Acids, Peptides, and ProteinsSuprofen
go.drugbank.com/drugs/DB00870ApprovedWithdrawnAn ibuprofen-type anti-inflammatory analgesic and antipyretic. It inhibits prostaglandin synthesis and has been proposed as an anti-arthritic. It is no longer approved for use in the United States.
Categories: Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-SteroidsCalaspargase pegol
go.drugbank.com/drugs/DB14730ApprovedInvestigationalThe asparagine specific enzyme is derived from Escherichia coli, as a conjugate of L-asparaginase (L-asparagine amidohydrolase) and monomethoxypolyethylene glycol (mPEG) with a succinimidyl carbonate ( … Calaspargase pegol, by _Shire_ pharmaceuticals, was approved by the FDA on December 20, 2018 for acute lymphoblastic anemia (ALL) [L4890].
Categories: Enzymes and Coenzymes, Antineoplastic and Immunomodulating Agents